Richard Slansky
Vermögen: 22 811 $ am 31.05.2026
Vermögen: 22 811 $ am 31.05.2026
Richard B. Slansky currently works at Genenta Science SpA, as Chief Financial Officer from 2021 and CN Biosciences, Inc., as Chief Financial Officer.
Mr. Slansky also formerly worked at Quick Strike Resources, Inc., as Director, Chief Executive & Financial Officer from 2002 to 2003, Path 1 Network Technologies, Inc., as CFO, Secretary, VP-Administration & Operations from 2000 to 2002, SpaceDev, Inc., as President, Chief Financial Officer & Secretary, Star Equity Holdings, Inc., as Chief Financial Officer & Head-Investor Relations from 2010 to 2012, OncoSec Medical, Inc., as CFO, Secretary & Principal Accounting Officer, GenMark Diagnostics, Inc., as Chief Financial Officer from 2012 to 2014, and Biological Dynamics, Inc., as Chief Financial Officer.
Mr. Slansky received his Masters Business Admin degree from the University of Arizona and undergraduate degree from The Wharton School of the University of Pennsylvania.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GENENTA SCIENCE SPA 0.12% | 30.03.2026 | 22’147 ( 0.12% ) | 22 811 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Finanzdirektor/CFO | 20.05.2021 |
CN Biosciences, Inc.
CN Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops products used worldwide in disease-related life sciences research | Finanzdirektor/CFO | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Finanzdirektor/CFO | 16.07.2018 |
| GENMARK DIAGNOSTICS, INC. | Finanzdirektor/CFO | 13.05.2014 |
| STAR EQUITY HOLDINGS | Finanzdirektor/CFO | 20.04.2012 |
SpaceDev, Inc.
SpaceDev, Inc. Aerospace & DefenseElectronic Technology Develops spacecraft microsats, nanosats and maneuvering and orbital transfer vehicles | Finanzdirektor/CFO | - |
Quick Strike Resources, Inc. | Präsident | 01.02.2003 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
CN Biosciences, Inc.
CN Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops products used worldwide in disease-related life sciences research | Health Technology |
Path 1 Network Technologies, Inc.
Path 1 Network Technologies, Inc. Internet Software/ServicesTechnology Services Offers internet protocol video transport products | Technology Services |
SpaceDev, Inc.
SpaceDev, Inc. Aerospace & DefenseElectronic Technology Develops spacecraft microsats, nanosats and maneuvering and orbital transfer vehicles | Electronic Technology |
Star Operating Cos., Inc.
Star Operating Cos., Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures diagnostic imaging solutions, gamma cameras and construction | Health Technology |
OncoSec Medical, Inc.
OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
GenMark Diagnostics, Inc.
GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes immunoassays, serology, molecular & tissue diagnostic testing systems | Health Technology |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quick Strike Resources, Inc. | |
Biological Dynamics, Inc.
Biological Dynamics, Inc. Medical DistributorsDistribution Services Designs and develops cancer screening equipment | Distribution Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genenta Science SpA
Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen